Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.37% | 6.63% | 5.15% | 5.00% | 3.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.69% | -3.74% | -3.12% | 4.34% | 17.68% |
| Operating Income | 2.69% | 3.74% | 3.12% | -4.34% | -17.68% |
| Income Before Tax | 16.08% | 17.90% | 17.59% | -19.22% | -32.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.08% | 17.90% | 17.59% | -19.22% | -32.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.08% | 17.90% | 17.59% | -19.22% | -32.77% |
| EBIT | 2.69% | 3.74% | 3.12% | -4.34% | -17.68% |
| EBITDA | 2.83% | 4.22% | 4.09% | -2.81% | -15.43% |
| EPS Basic | 56.29% | 59.75% | 49.12% | 6.94% | -16.92% |
| Normalized Basic EPS | 48.38% | 53.39% | 41.17% | 23.59% | 0.99% |
| EPS Diluted | 56.29% | 59.75% | 49.12% | 6.94% | -16.92% |
| Normalized Diluted EPS | 48.38% | 53.39% | 41.17% | 23.59% | 0.99% |
| Average Basic Shares Outstanding | 74.67% | 104.39% | 78.01% | 51.13% | 25.08% |
| Average Diluted Shares Outstanding | 74.67% | 104.39% | 78.01% | 51.13% | 25.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |